低成本绿色循环工艺发酵生产丙酸联产维生素B12

对提取维生素B12后的费氏丙酸杆菌废菌体进行水解处理,考察以菌体水解液作为N源用于丙酸发酵的可行性.利用正交设计得到了提取维生素B12后的废菌体水解优化条件.基于此,构建利用植物纤维床反应器固定化生产丙酸联产维生素B12的低成本绿色循环工艺.结果表明:在4.5L的发酵体系中,单批次总糖质量浓度为200 g/L,发酵进行了5批次共1192h,丙酸生成总量为2 328.75 g,单批次丙酸质量浓度103.50 g/L,丙酸生产效率达0.43 g/(L·h),干菌质量浓度达到19.52 g/L.将菌体注入微好氧发酵罐中发酵获得112.8 mg/L维生素B12.     

维生素B12的光解研究及发酵液中维生素B12检测新方法的建立

采用HPLC检测法研究5,脱氧腺苷钴胺素和甲基基钴胺素的水溶液在不同光源及不同照度下的光解情况,结果表明随着光能量的增加光解速度加快。利用脱氧腺苷钴胺素的光解性质,探索了一种检测发酵液中维生素B12含量的新方法。将含有钴胺素的细胞破碎液完全光解后,测定光解后的产物羟基钴胺素,以此来确定维生素B12产量。此方法简便快速、重复性好,可应用于发酵生产维生素B12的各个环节。     

费氏丙酸杆菌两个亚种的分离与鉴定

用亨格特（Hungate）厌氧技术从不同奶制品分离出3株丙酸杆菌Propionibacterium,编号为PTC－1,PTC－2和PTC－3。细胞呈多形态,杆状,革兰氏阳性,不形成芽孢,不运动,菌落在PYG深层洋菜中呈双凸透镜状,白至土黄色,从葡萄糖、乳糖等8种碳水化合物发酵产酸,葡萄糖发酵产物包括大量丙酸和乙酸,少量异丁酸,琥珀酸和CO₂。厌氧至耐氧。PTC－1的DNA的GC百分含量测定值为67.8mol％（Tm）。三株菌的特性很接近,只在硝酸盐还原和牛奶凝固特性有差     

脱氧腺苷钴胺素生物合成途径中一种中间产物的研究

在费氏丙酸杆菌（Propionibacterium freudenreichii）发酵生产维生素B12的研究中,分离到脱氧腺苷钴胺素合成途径中一种关键而稳定的中间产物。该物质在维生素B12发酵过程中大量积累,当添加前体物质5,6-二甲基苯并咪唑(DMB)后可完全转化为脱氧腺苷钴胺素,光谱和质谱分析其应是脱氧腺苷钴胺素合成途径的中间产物－腺苷钴啉醇酰胺。对此中间产物的研究可深入了解厌氧合成脱氧腺苷钴胺素的代谢途径,并运用代谢调控手段优化工艺,指导厌氧发酵生产维生素B12的生产实践。     

发酵法生产维生素B_(12)

日本石油公司开发了发酵法生产维生素B_(1 2),(Ⅰ)的技术。     

一种农杆菌介导的赤霉菌CCRC3.572的转化方法

目的:建立农杆菌Ti质粒介导的转化赤霉菌的新方法。方法:以农杆菌Ti质粒pCAMBIA0390为基础,构建带有潮霉素抗性基因表达盒的双元载体,并用农杆菌介导的方法转化赤霉菌。结果:构建了双元载体pCAMBIA0390-hph(PgpdA),并获得了具有潮霉素抗性的赤霉菌转化子。结论:农杆菌介导的方法适于赤霉菌的转化,为赤霉菌的遗传研究提供了一种新的手段。     

维生素B12的生物合成、发酵生产与应用

维生素B12(VB12)是一种重要的动物和人类营养因子, 广泛应用于饲料、食品和医药卫生领域。中国已成为全球VB12的主要产地, 2007年产量为27 t, 占全球总产量的77%。VB12是目前已发现的最大、最复杂的维生素分子, 化学合成极其困难, 所有VB12产品均采用生物发酵制备其主体结构。VB12主要由古生菌和一些真细菌通过有氧或厌氧两种途径合成, 工业上主要采用费式丙酸菌(Propionibacterium freudenrechii）和脱氮假单胞菌(Pseudomonas denitrificans)进行发酵生产。综述了VB12的基本性质, 生物合成途径, 以及发酵生产工艺, 并对VB12的应用与市场前景作了分析。     

维生素B12的生物合成、发酵生产与应用

维生素B12(VB12)是一种重要的动物和人类营养因子, 广泛应用于饲料、食品和医药卫生领域。中国已成为全球VB12的主要产地, 2007年产量为27 t, 占全球总产量的77%。VB12是目前已发现的最大、最复杂的维生素分子, 化学合成极其困难, 所有VB12产品均采用生物发酵制备其主体结构。VB12主要由古生菌和一些真细菌通过有氧或厌氧两种途径合成, 工业上主要采用费式丙酸菌(Propionibacterium freudenrechii）和脱氮假单胞菌(Pseudomonas denitrificans)进行发酵生产。综述了VB12的基本性质, 生物合成途径, 以及发酵生产工艺, 并对VB12的应用与市场前景作了分析。     

不同来源的尿卟啉原Ⅲ转甲基酶在脱氮假单胞菌中的表达及其对生产维生素B_(12)的影响

S-腺苷-L-甲硫氨酸依赖型尿卟啉原Ⅲ转甲基酶(S-adenosy-L-methionine uroprophyrinogen Ⅲ methyltransferase,SUMT)催化尿卟啉原Ⅲ(uroprophyrinogen Ⅲ,urogen Ⅲ)中心碳原子C-2和C-7甲基化生成前咕啉-2,是维生素B_(12)生物合成途径中的一步关键酶。本文分别克隆了荚膜红细菌来源的RCcob A1,RCcob A2和脱氮假单胞菌来源的PDcob A,并在VB_(12)生产菌株脱氮假单胞菌中过表达和发酵。通过对三株重组菌维生素B_(12)发酵结果分析可知,SUMT(PDcob A),SUMT1(RCcob A1)和SUMT2(RCcob A2)的表达有利于维生素B_(12)产量的提高,与对照菌株相比分别提高了16.48%,10.2%和31.86%。根据摇瓶发酵的结果在5 L发酵罐上进行了放大实验,p BBR122-PblaRCcob A2的产量为144.5 mg/L,相比对照菌p BBR122-Pbla(111.3 mg/L)产量提高了29.83%左右。结论:SUMT的表达可以在一定程度上解除维生素B_(12)合成途径中的瓶颈,提高维生素B_(12)产量。     

Biosynthesis of vitamin B12 by Propionibacterium freudenreichii subsp. shermanii ATCC 13673 using liquid acid protein residue of soybean as culture medium

Vitamin B12 deficiency still persists, mainly caused by low intake of animal food products affecting vegetarians, vegans, and populations of underdeveloped countries. In this study, we investigate the biosynthesis of vitamin B12 by potential probiotic bacterium using an agroindustry residue, the liquid acid protein residue of soybean (LAPRS), as a low-cost, animal derivate-free alternative culture medium. Cultures of Propionibacterium freudenreichii subsp. shermanii ATCC 13673 growing in LAPRS for vitamin B12 biosynthesis were studied using the Plackett–Burman experimental approach, followed by a central composite design 2² to optimize the concentration of significant variables. We also performed a proteolytic treatment of LAPRS and evaluated the optimized–hydrolyzed medium influence on the microbial growth and metabolism in shaker flask and bioreactor experiments. In this all-plant source medium, P. freudenreichii subsp. shermanii produced high concentrations of cells and high amounts of vitamin B12 (0.6 mg/g cells) after process optimization. These results suggest the possibility of producing vitamin B12 by a potential probiotic bacterium in a very cheap, animal derivate-free medium to address the needs of specific population groups, at the same time reducing the production costs of this essential vitamin.     

Simulation of fermentation conditions for vitamin B12 biosynthesis from whey

Vitamin B₁₂ production in fermentation of Propionibacterium shermanii and Propionibacterium arl AKU 1251 in whey permeate medium has been studied. The observed results and simulated expected values obtained by fitting statistical equations to the recorded data showed that 24 h old inoculum, 5 mg iron l^?1 and 4% whey lactose were optimal for vitamin B₁₂ biosynthesis in both strains when fermentation was carried out under anerobic (84 h) and aerobic (84 h) conditions at 30°C. The supplementation of whey medium with 0.5% (NH₄)₂HPO₄ enhanced further the metabolite yield; however, the preference for a mixed carbon source (lactose + d-glucose or lactose + d-fructose) at different levels varied in the strains under study. P. shermanii, under optimal cultural conditions, was found to be a better strain than Propionibacterium arl AKU, 1251 in fermenting whey lactose for product (vitamin B₁₂) formation.     

Production of branched-chain aroma compounds by Propionibacterium freudenreichii: links with the biosynthesis of membrane fatty acids

Aims: Short branched-chain fatty acids (BCFAs) are cheese flavour compounds, which result from the conversion of branched-chain amino acids (BCAAs). In Swiss cheese, the production of short BCFAs is mainly performed by Propionibacterium freudenreichii and is strain dependent. Our aim was to investigate the possible links between the biosynthesis of short BCFAs and membrane BCFAs in P. freudenreichii. Methods and Results: Short and membrane BCFAs were analysed by gas chromatography-mass spectrometry. Two strains differing in their capacities to release short BCFAs were selected. Tri-deuterated-labelled leucine was used in both strains as a precursor of short extracellular iso-BCFAs and of membrane iso-BCFAs. The proportions of anteiso : iso BCFAs synthesized varied as function of the BCAAs provided in the growth medium, from 72 : 28 to 100 : 0, with leucine and valine, and with isoleucine as sole BC precursors, respectively. The branching pattern of short BCFAs exactly matched that of membrane BCFAs, whatever the exogenous BCAAs provided. Conclusions: The biosynthesis of short BCFAs is closely related to that of membrane BCFAs in P. freudenreichii. Significance and Impact of the Study: The biosynthesis of short BCFAs in P. freudenreichii depends more on the strain than on the presence of exogenous BC precursors.     

Processing of glutathionylcobalamin by a bovine B12 trafficking chaperone bCblC involved in intracellular B12 metabolism

Glutathionylcobalamin (GSCbl) is a biologically relevant vitamin B₁₂ derivative and contains glutathione as the upper axial ligand thought formation of a cobalt-sulfur bond. GSCbl has been shown to be an effective precursor of enzyme cofactors, however processing of the cobalamin in intracellular B₁₂ metabolism has not been fully elucidated. In this study, we discovered that bCblC, a bovine B₁₂ trafficking chaperone, catalyzes elimination of the glutathione ligand from GSCbl by using the reduced form of glutathione (GSH). Deglutathionylation products are base-off cob(II)alamin and glutathione disulfide, which are generated stoichiometrically to GSH. Although cob(I)alamin was not detected due to its instability, deglutathionylation is likely analogous to dealkylation of alkylcobalamins, which uses the thiolate of GSH for nucleophilic displacement. The catalytic turnover number for the deglutathionylation of GSCbl is ?1.62 ± 0.13 min⁻¹, which is, at least, an order of magnitude higher than that for elimination of upper axial ligands from other cobalamins. Considering the prevalence of GSH at millimolar concentrations in cells, our results explain the previous finding that GSCbl is more effective than other cobalamins for synthesis of enzyme cofactors.     

利用纤维床反应器固定化发酵生产丙酸

构建了一种纤维床反应器(FBB), 并将其应用于丙酸的生产。将棉纤维绕成桶状, 固定于反应器中, 即可用于丙酸固定化发酵。以40 g/L的葡萄糖为碳源, 与游离细胞相比, 利用FBB生产丙酸, 丙酸产量由14.58 g/L提高至20.41 g/L, 发酵时间由120 h缩短至60 h。研究了不同糖浓度条件下FBB生产丙酸情况, 并将补料策略应用于丙酸发酵中。结果表明: 补料发酵能够有效改善Propionibacterium freudenreichii CCTCC M207015在高糖条件下丙酸对葡萄糖转化率较低、副产物较多的问题。经补料发酵280 h, 丙酸产量达45.91 g/L, 丙酸质量约占有机酸总质量比例为72.31%。     

透明颤菌vgb基因在脱氮假单胞菌中的表达及对维生素B12合成的碳中心代谢流分析

在为维生素B₁₂生产菌株脱氮假单胞菌确立合适的接合转移操作条件的基础上,通过单交换的方式,将vgb基因整合到脱氮假单胞菌染色体上,获得了vgb重组菌株Pvgb-16,并通过¹³C同位素标记实验,探索VHb蛋白对脱氮假单胞菌碳中心代谢流变化和维生素B₁₂合成的影响。研究结果表明,在相同的供氧条件下,vgb重组菌株Pvgb-16拥有更高的比生长速率和比产物合成速率,与出发菌株相比分别提升了22%和52%。碳代谢通量分布分析表明,vgb重组菌株Pvgb-16的PP途径改善,提升了NADPH合成通量;甘氨酸由甜菜碱合成的通量上升,促进了前体物质氨基乙酰丙酸的合成,进一步加速维生素B₁₂的合成。总体来看,含vgb基因的重组菌株与出发菌株相比在促进菌体的生长、维生素B₁₂的合成速率及得率上都有显著效果,对进一步的发酵生产应用研究具有重要意义。     

费氏丙酸杆菌费氏亚种生长特性及对致病菌和益生菌作用探讨

目的对1株费氏丙酸杆菌费氏亚种生长特性及发酵代谢物的抑菌和促生长作用进行研究。方法将费氏丙酸杆菌费氏亚种无细胞发酵上清液分别与5株致病菌和3株益生菌添加至24孔板中进行培养,通过测定A_(600 nm)值的变化来研究发酵代谢物的抑菌和促生长作用。结果发酵代谢物中的抑菌成分含量随发酵时间的延长而增加,到第6天后增长趋于平缓。当发酵上清液添加量达到400μL时,溶血性链球菌被完全抑制,达到600μL时,金黄色葡萄球菌、沙门菌、单核细胞增生李斯特菌和大肠埃希菌实验组A_(600 nm)值较对照组分别下降76.1%、68.5%、60.2%和43.9%,而长双歧杆菌和婴儿双歧杆菌实验组A_(600 nm)值较对照组分别上升17.1%和41.5%。结论费氏丙酸杆菌费氏亚种发酵代谢物对5株致病菌均表现出不同程度的抑菌效果,对2株双歧杆菌的生长有较明显的促进作用。